Rationale and protocol of the Study Of diabetic Nephropathy with AtRasentan (SONAR) trial: A clinical trial design novel to diabetic nephropathy

Author:

Heerspink Hiddo J. L.1ORCID,Andress Dennis L.2,Bakris George3,Brennan John J.2,Correa-Rotter Ricardo4,Dey Jyotirmoy2,Hou Fan Fan5,Kitzman Dalane W.6,Kohan Donald7,Makino Hirofumi8,McMurray John9,Perkovic Vlado10,Tobe Sheldon11,Wigderson Melissa2,Parving Hans-Henrik1213,de Zeeuw Dick1

Affiliation:

1. Department of Clinical Pharmacy and Pharmacology; University of Groningen, University Medical Center Groningen; Groningen The Netherlands

2. Pharma Development, AbbVie; North Chicago Illinois

3. Department of Medicine, Section of Endocrinology, ASH Comprehensive Hypertension Center; University of Chicago Medicine and Biological Sciences; Chicago Illinois

4. Department of Nephrology and Mineral Metabolism, National Medical Science and Nutrition Institute Salvador Zubirán; Mexico City Mexico

5. Division of Nephrology; Nanfang Hospital, Southern Medical University, National Clinical Research Center for Kidney Disease; Guangzhou China

6. Department of Internal Medicine; Wake Forest School of Medicine; Winston-Salem North Carolina

7. Division of Nephrology; University of Utah Health Sciences Center; Salt Lake City Utah

8. Department of Nephrology, Rheumatology, Endocrinology and Metabolism; Okayama University; Okayama-Shi Japan

9. BHF Cardiovascular Research Centre; University of Glasgow; Glasgow UK

10. Faculty of Medicine; George Institute for Global Health, UNSW Sydney; Newtown Australia

11. Department of Medicine, Division of Nephrology; Sunnybrook Health Sciences Centre, University of Toronto and the Northern Ontario School of Medicine; Toronto Canada

12. Department of Medical Endocrinology, Rigshospitalet; University of Copenhagen; Copenhagen Denmark

13. Faculty of Health Science; Aarhus University; Aarhus Denmark

Funder

AbbVie

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3